Zur Zeit liegt uns keine Inhaltsangabe vor.
Inhaltsverzeichnis
I. Phenothiazine Derivatives. - A. Structure-activity Relationships. - B. Peripheral Effects. - C. Central Effects. - D. Endocrine Effects. - E. Metabolic Fate of Phenothiazines. - F. Habituation and Withdrawal. - G. Adverse Reactions and Treatment Risks. - II. Butyrophenones. - A. Structure Activity Relationships. - B. Peripheral Effects. - C. Central Effects. - D. Biochemical Effects. - E. Adverse Reactions and Dangers. - III. Reserpine and Reserpine-like Agents. - A. Structure-activity Relationships. - B. Peripheral Effects. - C. Central Effects. - D. Endocrine Effects of Reserpine. - E. Metabolic Fate of Reserpine. - F. Adverse Reactions and Dangers. - IV. Minor Tranquilizers. - A. Central Effects. - B. Peripheral Effects. - C. Metabolic Studies. - D. Adverse Reactions. - V. Monoamine Oxidase Inhibitors. - A. The Physiologic Significance of Monoamine Oxidase. - B. Classification of MAO-inhibitors and their Structure-activity Relationship. - C. Biochemical and Pharmacologic Effects of MAO-inhibitors. - D. Fate of MAO-inhibitors in the Body. - E. Adverse Reactions and Dangers. - VI. Thymoleptics. - A. Peripheral Effects. - B. Central Effects. - C. Metabolic Fate. - D. Adverse Reactions. - VII. Chemical Structures, General Clinical Use and Daily Human Rose Range of the most Frequently Used Psychotherapeutic Drugs. - Abbreviations.